World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
33814
World Ranking
11239
National Ranking
443

Harald J. Hoekstra publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harald J. Hoekstra sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 610 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harald J. Hoekstra D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harald J. Hoekstra sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harald J. Hoekstra is affiliated with the University Medical Center Groningen in the Netherlands. Their primary field of study is Medicine, with a focus on several subfields including Oncology, Epidemiology, Immunology, Artificial Intelligence, and Astronomy and Astrophysics. Hoekstra's research contributions span topics related to cutaneous melanoma detection and management, nonmelanoma skin cancer studies, CAR-T cell therapy research, immunotherapy and immune responses, astronomy and astrophysical research, cancer immunotherapy and biomarkers, and the application of AI in cancer detection.

Their recent scientific publications include:

  • Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma, 2022, JAMA Surgery
  • The association between active tumor volume, total lesion glycolysis and levels of S-100B and LDH in stage IV melanoma patients, 2020, European Journal of Surgical Oncology
  • The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years, 2020, Annals of Surgical Oncology
  • Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study), 2022, Annals of Surgery
  • Increase of Sentinel Lymph Node Melanoma Staging in The Netherlands; Still Room and need for Further Improvement, 2020, Melanoma Management

Frequent coauthors collaborating with Hoekstra include:

  • Schelto Kruijff
  • E. Franceschi
  • C. Giocoli
  • Marc Moncrieff
  • Eric A. Deckers

The most common publication venues for Hoekstra's work are:

  • arXiv (Cornell University)
  • Annals of Surgical Oncology
  • Melanoma Management
  • Astronomy and Astrophysics
  • JAMA Surgery

Harald J. Hoekstra's research areas intersect clinical oncology and translational medicine, particularly in the surveillance and management of melanoma patients. Their work reflects a multidisciplinary approach integrating clinical follow-up studies, tumor biomarker analysis, and innovative methodologies involving artificial intelligence applications in cancer detection. The combination of oncology and astronomy-related topics also highlights their engagement in cross-disciplinary scientific inquiries.

Best Publications

  • Sentinel-node biopsy or nodal observation in melanoma

    Donald L. Morton;John F. Thompson;Alistair J. Cochran;Nicola Mozzillo

  • Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

    D. L. Morton;J. F. Thompson;A. J. Cochran;N. Mozzillo

  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka

  • Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. A. Peccatori;H. A. Azim;R. Orecchia;Harald Hoekstra

  • Sentinel node biopsy for early-stage melanoma - Accuracy and morbidity in MSLT-I, an international multicenter trial

    Donald L. Morton;Alistair J. Cochran;John F. Thompson;Robert Elashoff

  • Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

    Alexander A.M.M. Eggermont;Heimen Schraffordt Koops;Joseph J.M. Klausner;Bin B.B.R. Kroon

  • Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

    A M Eggermont;H Schraffordt Koops;D Liénard;B B Kroon

  • Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    Penella J. Woll;Peter Reichardt;Axel Le Cesne;Sylvie Bonvalot

  • Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

    Alexandra W. van den Belt-Dusebout;Ronald de Wit;Jourik A. Gietema;Simon Horenblas

  • The impact of parental cancer on children and the family: a review of the literature

    Annemieke Visser;Gea A. Huizinga;Winette T.A. van der Graaf;Harald J. Hoekstra

  • Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study.

    Pace participants;R A Audisio;D Pope;H S J Ramesh

  • Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

    Mwn Nijsten;P Olinga;Ege de Vries

  • Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review

    J.S Rietman;P.U Dijkstra;H.J Hoekstra;W.H Eisma

  • [18F]FLT-PET in oncology: current status and opportunities.

    Lukas Been;Albert Suurmeijer;David Catharina Petrus Cobben;Pieter Jager

  • Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model

    Aren van Waarde;David C P Cobben;Albert J H Suurmeijer;Bram Maas

  • Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

    Bryan H. Burmeister;Michael A. Henderson;Jill Ainslie;Richard Fisher

  • The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis

    E Bastiaannet;H Groen;P.L Jager;D.C.P Cobben

  • Detection of unknown occult primary tumors using positron emission tomography

    Annemieke C. Kole;Omgo E. Nieweg M.D.;Omgo E. Nieweg M.D.;Jan Pruim M.D.;Harald J. Hoekstra M.D.

  • Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins

    Boudewijn E. C. Plaat;Harry Hollema;Willemina M. Molenaar;Gerben H. Torn Broers

  • Follow-up in patients with localised primary cutaneous melanoma.

    Anne Brecht Francken;Esther Bastiaannet;Harald J Hoekstra

Frequent Co-Authors

Josette E. H. M. Hoekstra-Weebers
Josette E. H. M. Hoekstra-Weebers University Medical Center Groningen
John F. Thompson
John F. Thompson University of Sydney
Rolf H. Sijmons
Rolf H. Sijmons University of Groningen
Michael A. Henderson
Michael A. Henderson Peter MacCallum Cancer Centre
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Alistair J. Cochran
Alistair J. Cochran University of California, Los Angeles
Omgo E. Nieweg
Omgo E. Nieweg Royal Prince Alfred Hospital
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing in the medical field goes beyond traditional MD programs. Many students and professionals explore related online degrees for flexibility and career growth. Nurses seeking leadership or specialized roles may consider the shortest post master's dnp program to quickly attain a terminal nursing credential. Others may look for online dnp programs without clinicals to reduce hands-on requirements while focusing on policy or education tracks.

For those starting out, becoming a licensed practical nurse is a popular entry-point. Fast track lpn programs offer accelerated options, helping students join the workforce more quickly. In addition, the growing demand for mental health professionals is increasing interest in psych np online programs, enabling nurses to specialize and deliver vital psychiatric care.

These online pathways provide flexibility and diverse opportunities. Prospective students should assess program requirements, clinical components, and career outcomes to find the best fit for their goals.

Best Scientists Citing Harald J. Hoekstra

Trending Scientists

Recently Published Articles